Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tejaas: reverse regression increases power for detecting trans-eQTLs.

Saikat Banerjee1, Franco L Simonetti2, Kira E Detrois2,3

  • 1Quantitative and Computational Biology, Max-Planck Institute for Biophysical Chemistry, Göttingen, 37077, Germany. bnrj.saikat@gmail.com.

Genome Biology
|May 7, 2021
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronicity and comorbidities: Is estimated longer duration of obstructive sleep apnoea linked to higher cardiometabolic risk?

Lung India : official organ of Indian Chest Society·2026
Same author

Normal spirometry with high and asthma-defining bronchodilator responsiveness: An appraisal from real-life data.

Lung India : official organ of Indian Chest Society·2026
Same author

Diagnostic yield of gravity based diagnostic thoracentesis in suspected malignant pleural effusion (GBTIME): A pilot study.

Respiratory medicine·2026
Same author

Repurposed amitriptyline hydrochloride against fluconazole-resistant Candida albicans targeting efflux pump Pdr5, an ABC transporter: In vitro and in silico study with clinical validation.

Diagnostic microbiology and infectious disease·2026
Same author

HuR-driven reversible mitochondrial shuttling buffers cytosolic miRNA levels in hepatic cells.

The Journal of biological chemistry·2026
Same author

Neutrophil CD14 is a driver and a therapeutic target for deep vein thrombosis.

Blood advances·2026

Tejaas identifies trans-acting expression quantitative trait loci (trans-eQTLs), crucial for understanding complex diseases. This method effectively predicts numerous trans-eQTLs across tissues, revealing regulatory mechanisms.

Area of Science:

  • Genetics
  • Genomics
  • Systems Biology

Background:

  • Trans-acting expression quantitative trait loci (trans-eQTLs) explain a significant portion of gene expression heritability.
  • Identifying trans-eQTLs is difficult due to small effect sizes, tissue specificity, and extensive multiple testing.
  • Understanding trans-eQTLs is key to uncovering the genetic basis of complex diseases.

Purpose of the Study:

  • To develop and validate a novel computational method, Tejaas, for robust trans-eQTL prediction.
  • To identify a comprehensive set of trans-eQTLs across multiple human tissues.
  • To investigate the regulatory roles and disease relevance of predicted trans-eQTLs.

Main Methods:

  • Tejaas employs L2-regularized "reverse" multiple regression to predict trans-eQTLs by regressing SNPs on all genes.

Related Experiment Videos

  • An unsupervised k-nearest neighbor method is integrated to effectively remove confounding factors.
  • The approach aggregates evidence from numerous small trans-effects, mitigating issues with strong gene expression correlations.

    • Main Results:

    • Tejaas successfully predicted 18,851 unique trans-eQTLs across 49 diverse tissues from the Genotype-Tissue Expression (GTEx) project.
    • Predicted trans-eQTLs show significant enrichment in regulatory regions, including open chromatin and enhancers.
    • A substantial number of identified trans-eQTLs overlap with single nucleotide polymorphisms (SNPs) associated with various diseases.

    Conclusions:

    • Tejaas provides a powerful and scalable method for discovering trans-eQTLs, advancing the study of gene regulation.
    • The findings highlight the importance of tissue-specific transcriptional regulation in complex disease etiology.
    • The identified trans-eQTLs offer valuable insights into the genetic architecture of human diseases and potential therapeutic targets.